Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101159262 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-843X (Electronic) Linking ISSN: 15409996 NLM ISO Abbreviation: J Womens Health (Larchmt) Subsets: MEDLINE
    • Publication Information:
      Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., [2002]-
    • Subject Terms:
      Melanoma* ; Skin Neoplasms*; Aged ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Sex Characteristics ; Melanoma, Cutaneous Malignant
    • Abstract:
      Background: This study aims to provide a comprehensive overview of sex-related characteristics of cutaneous malignant melanoma (CMM), with special reference to its incidence, clinicopathological profile, overall survival, and treatment-related costs. Methods: This retrospective cohort study included all 1,279 CMM patients who were registered in 2015 in the Veneto Cancer Registry (a population-based registry including all 4,900,000 regional residents). The by-sex comparisons included tumor stage and site, histological subtype, and other clinical-pathological variables. A Cox regression analysis was used to test the association between sex and survival, adjusting for the main covariates. Treatment costs were calculated by linking patients with several administrative regional databases. Results: Age-specific incidence rates were significantly higher for men among people >50 years old. For men, the trunk was the most common primary site (59.3%), whereas for women the lower limbs (32.1%) were the most common primary site, followed by the trunk (31.8%), which was lower than for men ( p  < 0.001). At presentation, the frequency of early stage CMM was higher among women, who also featured a significantly lower risk of death ( p  = 0.016), after adjusting for covariates. Men also incurred higher costs for melanoma treatment in the first year after their diagnosis. Conclusions: Among younger adults, CMM was more common in women, whereas among older adults, it was more common in men. Sex also influences patients' histopathological characteristics at diagnosis. Women had better overall survival after adjusting for demographic, pathological, and clinical profiles. The costs of treatment were also lower for women with CMM.
    • References:
      J Eur Acad Dermatol Venereol. 2016 May;30(5):789-93. (PMID: 25807966)
      EJC Suppl. 2013 Sep;11(2):81-91. (PMID: 26217116)
      J Natl Cancer Inst. 2015 Aug 20;107(11):. (PMID: 26296643)
      Melanoma Res. 2017 Dec;27(6):607-618. (PMID: 28800027)
      Cancer. 2000 Jul 15;89(2):342-7. (PMID: 10918164)
      J Eur Acad Dermatol Venereol. 2019 Mar;33(3):504-510. (PMID: 30408246)
      Melanoma Res. 2011 Jun;21(3):244-52. (PMID: 21540649)
      Med Pediatr Oncol. 2002 Jan;38(1):1-10. (PMID: 11835231)
      Ann Oncol. 2008 Mar;19(3):583-9. (PMID: 17974555)
      J Exp Clin Cancer Res. 2012 Nov 01;31:91. (PMID: 23116062)
      Int J Cancer. 2011 May 1;128(9):2158-65. (PMID: 20607832)
      Lancet Oncol. 2020 Oct;21(10):1258-1260. (PMID: 33002433)
      Cancer Med. 2017 Oct;6(10):2203-2212. (PMID: 28879661)
      Eur J Surg Oncol. 2020 Jun;46(6):976-981. (PMID: 32146052)
      J Am Acad Dermatol. 1992 Jun;26(6):914-9. (PMID: 1607408)
      Pigment Cell Melanoma Res. 2010 Jun;23(3):352-64. (PMID: 20218981)
      J Clin Oncol. 2013 Jun 20;31(18):2337-46. (PMID: 23690423)
      JAMA Dermatol. 2020 Jan 1;156(1):57-64. (PMID: 31721989)
      Eur J Cancer. 2012 Sep;48(14):2175-82. (PMID: 22480965)
      J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:6-12. (PMID: 30811690)
      Arch Dis Child. 2006 Feb;91(2):131-8. (PMID: 16326797)
      Cancers (Basel). 2020 Jul 07;12(7):. (PMID: 32645881)
      Arch Pathol Lab Med. 2020 Apr;144(4):500-522. (PMID: 32057276)
      Melanoma Res. 2005 Apr;15(2):125-32. (PMID: 15846146)
      Cancer Causes Control. 2011 Jun;22(6):885-97. (PMID: 21472378)
      Dermatol Ther. 2020 Nov;33(6):e14131. (PMID: 32757248)
      PLoS One. 2012;7(3):e32955. (PMID: 22412958)
      J Surg Oncol. 2004 Jul 1;86(4):172-8. (PMID: 15221923)
      Lancet Public Health. 2019 Dec;4(12):e645-e657. (PMID: 31759893)
      JAMA Dermatol. 2020 May 1;156(5):553-560. (PMID: 32211827)
      Cancer Manag Res. 2010 Aug 17;2:197-211. (PMID: 21188111)
    • Contributed Indexing:
      Keywords: histopathological characteristics; incidence; melanoma; sex disparities; survival
    • Publication Date:
      Date Created: 20220125 Date Completed: 20220720 Latest Revision: 20231213
    • Publication Date:
      20240105
    • Accession Number:
      PMC9299528
    • Accession Number:
      10.1089/jwh.2021.0223
    • Accession Number:
      35076310